Bitter melon (momordica charantia) and the effects of diabetes disease

Kudret narı (Momordica charantia) diyabetli hastaların kan glukoz seviyelerinin düşürülmesi için kullanılmış öncelikli bir alternatif tedavidir. Hayvan ve insanlarda yapılan çalışmalar kudret narında hipoglisemik maddelerin var olduğunu göstermiştir.

Kudret narı (momordica charantia) ve diyabet hastalığında etkileri

Bitter melon (Momordica charantia) is an alternative therapy that has primarily been used for lowering blood glucose levels in patients with diabetes mellitus. Bitter melon's hypoglyecemic ingredients have been shown in animal and human studies.

PDF

___

Akgün-Dar, K., Bolkent, S., Yanardag, R., Tunali, S., 2007. Vanadyl sulfate protects against streptozotocin-induced morphological and biochemical changes in rat aorta. Cell Biochem Funct. 25(6): 603-9.
Bailey, C. J., Flatt, P. R., Day, C., 1990. Hypoglycaemic compounds from plants. NewAntidiabetic Drugs. Nishimura Ltd, Japan, 267278.
Basch, E., Gabardi, S., Ulbricht, C., 2003. Bitter melon (Momordica charantia): a review of effi cacy and safety. Am J Health Syst Pharm. 60 (4): 356-9.
Cummings, E., Hundal, H.S., Wackerhage, H., Hope, M., Belle, M., Adeghate, E. and Singh, J., 2004. Momordica charantia fruit juice stimulates glucose and amino acid uptakes in L6 myotubes. Molecular and Cellular Biochemistry 261: 99104.
Jayasooriya, A. P,. Sakono, M., Yukizaki, C., Kawano, M., Yamamoto, K., Fukuda, N., 2000. Effects of Momordica charantia powder on serum glucose levels and various lipid parameters in rats fed with cholesterol-free and cholesterol-enriched diets, Journal of Ethnopharmacology. 72 (1-2): 331-6.
Kulkarni, R.D., Gaitonde, B.B., 1962. Potentiation of tobutamide action by jasad bhasma and karela (Momordica charantia). Indian J Med Res. 50: 715-9.
Kumar, P.J., Clark, M., 2002. Diabetes mellitus and other disorders of metabolism. Textbook of Clinical Medicine. Saunders, (London). 10691152.
Kumar, D. S., Sharathnath, K. V., Yogeswaran, P., Harani, A., Sudhakar, K., Sudha, P., Banji, D., 2010. A Medicinal Potency Of Momordica Charantia. International Journal of Pharmaceutical Sciences Review and Research. Volume 1, Issue 2, Article 018.
Manabe, M., Takenaka, R., Nakasa, T., Okinaka, O., 2003. Induction of anti-inflammatory responses by dietary Momordica charantia L. (bitter gourd). Biosci Biotechnol Biochem. 67: 2512-2517.
Mitra, A. and Bhattacharya, D., 2006. Effect of Fatty Substances on Health particularly to Patients Suffering from NIDDM and Dyslipidaemia. J. Interacademicia, 10 (1): 74-85.
Nerurkar, P.V., Lee, Y.K., Motosue, M., Adeli, K., Nerurkar, V.R., 2008. Momordica charantia (bitter melon) reduces plasma apolipoprotein B-100 and increases hepatic insulin receptor substrate and phosphoinositide-3 kinase interactions. Br J. Nutr. 1-9.
Oishi, Y., Sakamoto, T., Udagawa, H., Taniguchi, H., Kobayashi-Hattori, K., Ozawa, Y., Takita, T., 2007. Inhibition of increases in blood glucose and serum neutral fat by Momordica charantia saponin fraction. Biosci Biotechnol Biochem. 71, 735.
Platel, K., Srinivasan, K., 1997. Plant foods in the management of diabetes mellitus: Vegetables as potential hypoglycaemic agents. Nahrung. 41: 6874.
Sarkar, S., Pranava, M. and Marita, R., 1996. Demonstration of the hypoglycemioc action of Momordica charantia in a validate animal model of diabetes. Pharmacol. Res. 33: 1-4.
Sharma, S., Sharma, M. C., Kohlıb, D. V., Chaturvedı, S. C., 2009. School of Pharmacy, Devi Ahilya Vishwavidyalaya, Khandwa Road, Indore. Formulation, Evaluation, Wound Healing Tudies Of Benzene-95 % Absolute Ethanol Extract Of Leaves. Journal of Optoelectronics and Biomedical Materials Vol. 1, Issue 4. 375 378.
Shetty, A. K., Suresh, G., Sambaiah, K. K., and Salimath, P. V., 2005. "Effect of bitter gourd (Momordica charantia) on glycaemic status in streptozotocin induced diabetic rats". Plant Foods Hum Nutr, 60 (3): 10912.
Shibib, B.A., Khan, I.A. and Rahmam, R., 1993. Hypoglycemic activity Coccinia Indica and Momardia charantia in diabetic rats. Depression of the hepatic gluconeogenic enzyme glucoseb -6-phasphatase and elevation of both liver and red-cell shunt enzyme glucose -6-dehydrogenase. Biochem J. 292: 267-270.
Shih, C.C., Lin, C.H., Lin, W.L., Wu, J.B., 2009. Momordica charantia extract on insulin resistance and the skeletal muscle GLUT4 protein in fructose-fed rats. J Ethnopharmacol. 123 (1): 82-90.
Yadav, U. C. S., Moorthy, K., Baquer, N. Z., 2005. Combined treatment of sodium orthovanadate and Momordica charantia fruit extract prevents alterations in lipid profile and lipogenic enzymes in alloxan diabetic rats, Molecular and Cellular Biochemistry, 268 (1-2): 111-120.